RE:RE:RE:RE:LHS & CC Pharma In Results > Email from IRThe 47M divesture of LHS note covers the $28M cc pharma purchase. An additional $35M is due based on performance for CC, but APHA can also recieve additional 10M from the LHS note liquidation. Cash and equivalents could be closer to 200M for Q3. This is a shoe-in hold for LT investors as it will reach profitability long before ACB CGC TLRY.... JMHO. If APHA sold over 5000KG and CC Pharma had a big 7 weeks (~55M), it's possible we match CGCs Q2 revenue. I am curious to see the value CC Pharma adds to Q2 $2.1B balance sheet.
Shadd76 wrote: Disagree. The SP hasn’t had nearly enough run up to generate a sell off, and with BOD announcements coming too, way too much buzz surrounding this company to
generate a sell off tomorrow.